Greenman Jane F 4
4 · BARR PHARMACEUTICALS INC · Filed Dec 29, 2008
Insider Transaction Report
Form 4
Greenman Jane F
Executive VP, Global HR
Transactions
- Disposition to Issuer
Stock Appreciation Rights
2008-12-23−45,000→ 0 totalExercise: $49.22From: 2008-11-11Exp: 2018-03-04→ Common Stock (45,000 underlying) - Disposition to Issuer
Stock Appreciation Rights
2008-12-23−30,000→ 0 totalExercise: $51.88From: 2008-11-11Exp: 2017-07-30→ Common Stock (30,000 underlying)
Footnotes (2)
- [F1]These options were cancelled pursuant to the merger agreement between the Issuer and Teva in exchange for the aggregate cash payment of $438,600, which represents the difference between the $66.50 per share price specified in the merger agreement and the option price of $51.88 per share.
- [F2]These options were cancelled pursuant to the merger agreement between the Issuer and Teva in exchange for the aggregate cash payment of $777,600, which represents the difference between the $66.50 per share price specified in the merger agreement and the option price of $49.22 per share.